Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients

Florentien E M In't Hout; Thessa N Scheele; Theresia M Westers; Canan Alhan; Carolien Duetz; Eline M P Cremers; Heleen A Visser-Wisselaar; Annelies Verbrugge; Dana A Chitu; Bert A Van der Reijden; Aniek O De Graaf; Arjan A Van de Loosdrecht; Joop H Jansen

doi:10.3324/haematol.2024.286157

Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients

Florentien E M In't Hout, Thessa N Scheele, Theresia M Westers, Canan Alhan, Carolien Duetz, Eline M P Cremers, Heleen A Visser-Wisselaar, Annelies Verbrugge, Dana A Chitu, Bert A Van der Reijden, Aniek O De Graaf, Arjan A Van de Loosdrecht, Joop H Jansen^*

^*Corresponding author for this work

Hematology

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

3 Downloads (Pure)

Original language	English
Pages (from-to)	772-776
Number of pages	5
Journal	Haematologica
Volume	110
Issue number	3
DOIs	https://doi.org/10.3324/haematol.2024.286157
Publication status	Published - Mar 2025

Access to Document

10.3324/haematol.2024.286157Licence: CC BY-NC-ND

Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patientsFinal published version, 1.62 MBLicence: CC BY-NC-ND

Cite this

In't Hout, F. E. M., Scheele, T. N., Westers, T. M., Alhan, C., Duetz, C., Cremers, E. M. P., Visser-Wisselaar, H. A., Verbrugge, A., Chitu, D. A., Van der Reijden, B. A., De Graaf, A. O., Van de Loosdrecht, A. A., & Jansen, J. H. (2025). Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients. Haematologica, 110(3), 772-776. https://doi.org/10.3324/haematol.2024.286157

@article{f839a21e7ea54317a99d831469433694,

title = "Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients",

author = "{In't Hout}, {Florentien E M} and Scheele, {Thessa N} and Westers, {Theresia M} and Canan Alhan and Carolien Duetz and Cremers, {Eline M P} and Visser-Wisselaar, {Heleen A} and Annelies Verbrugge and Chitu, {Dana A} and {Van der Reijden}, {Bert A} and {De Graaf}, {Aniek O} and {Van de Loosdrecht}, {Arjan A} and Jansen, {Joop H}",

year = "2025",

month = mar,

doi = "10.3324/haematol.2024.286157",

language = "English",

volume = "110",

pages = "772--776",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "3",

}

In't Hout, FEM, Scheele, TN, Westers, TM, Alhan, C, Duetz, C, Cremers, EMP, Visser-Wisselaar, HA, Verbrugge, A , Chitu, DA, Van der Reijden, BA, De Graaf, AO, Van de Loosdrecht, AA & Jansen, JH 2025, 'Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients', Haematologica, vol. 110, no. 3, pp. 772-776. https://doi.org/10.3324/haematol.2024.286157

Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients. / In't Hout, Florentien E M; Scheele, Thessa N; Westers, Theresia M et al.
In: Haematologica, Vol. 110, No. 3, 03.2025, p. 772-776.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients

AU - In't Hout, Florentien E M

AU - Scheele, Thessa N

AU - Westers, Theresia M

AU - Alhan, Canan

AU - Duetz, Carolien

AU - Cremers, Eline M P

AU - Visser-Wisselaar, Heleen A

AU - Verbrugge, Annelies

AU - Chitu, Dana A

AU - Van der Reijden, Bert A

AU - De Graaf, Aniek O

AU - Van de Loosdrecht, Arjan A

AU - Jansen, Joop H

PY - 2025/3

Y1 - 2025/3

U2 - 10.3324/haematol.2024.286157

DO - 10.3324/haematol.2024.286157

M3 - Comment/Letter to the editor

C2 - 39385740

SN - 0390-6078

VL - 110

SP - 772

EP - 776

JO - Haematologica

JF - Haematologica

IS - 3

ER -